- Home
- REI vs IMRX Comparison
REI vs IMRX Comparison
Compare REI & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REI
- IMRX
- Stock Information
- Founded
- REI 2004
- IMRX 2008
- Country
- REI United States
- IMRX United States
- Employees
- REI N/A
- IMRX N/A
- Industry
- REI Oil & Gas Production
- IMRX Biotechnology: Pharmaceutical Preparations
- Sector
- REI Energy
- IMRX Health Care
- Exchange
- REI Nasdaq
- IMRX Nasdaq
- Market Cap
- REI 208.6M
- IMRX 232.9M
- IPO Year
- REI N/A
- IMRX 2021
- Fundamental
- Price
- REI $1.09
- IMRX $6.05
- Analyst Decision
- REI
- IMRX Strong Buy
- Analyst Count
- REI 0
- IMRX 4
- Target Price
- REI N/A
- IMRX $17.75
- AVG Volume (30 Days)
- REI 2.5M
- IMRX 3.4M
- Earning Date
- REI 11-05-2025
- IMRX 11-12-2025
- Dividend Yield
- REI N/A
- IMRX N/A
- EPS Growth
- REI N/A
- IMRX N/A
- EPS
- REI 0.35
- IMRX N/A
- Revenue
- REI $318,900,835.00
- IMRX N/A
- Revenue This Year
- REI N/A
- IMRX N/A
- Revenue Next Year
- REI $9.58
- IMRX N/A
- P/E Ratio
- REI $3.16
- IMRX N/A
- Revenue Growth
- REI N/A
- IMRX N/A
- 52 Week Low
- REI $0.72
- IMRX $1.10
- 52 Week High
- REI $1.81
- IMRX $10.08
- Technical
- Relative Strength Index (RSI)
- REI 56.57
- IMRX 43.02
- Support Level
- REI $1.04
- IMRX $6.30
- Resistance Level
- REI $1.18
- IMRX $9.60
- Average True Range (ATR)
- REI 0.06
- IMRX 0.99
- MACD
- REI -0.00
- IMRX -0.41
- Stochastic Oscillator
- REI 52.50
- IMRX 0.74
About REI Ring Energy Inc.
Ring Energy Inc is an independent exploration and production company based in The Woodlands, Texas and is engaged in oil and natural gas development, production, acquisition, and exploration activities currently focused in the Permian Basin of Texas. The drilling operations of the company target the oil and liquid rich producing formations in the Northwest Shelf, the Central Basin Platform and the Delaware Basin all of which are part of the Permian Basin in Texas.
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.